Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma - PubMed (original) (raw)
Case Reports
. 2006 Dec;91(12):4776-80.
doi: 10.1210/jc.2006-0610. Epub 2006 Sep 12.
Affiliations
- PMID: 16968791
- DOI: 10.1210/jc.2006-0610
Case Reports
Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma
Christian Nasr et al. J Clin Endocrinol Metab. 2006 Dec.
Abstract
Context: GHRH excess from extracranial endocrine tumors is known to cause somatotroph hyperplasia and acromegaly. Hypothalamic gangliocytomas producing GHRH are also known to be associated with pituitary adenomas causing acromegaly.
Objectives: The objective of this study was to describe a case of acromegaly due to a pulmonary GHRH-secreting endocrine carcinoma with metastasis to the pituitary gland and to look at the peculiar histological features of this case.
Subject: The patient was a 44-yr-old woman who was diagnosed with a biopsy-proven metastatic pulmonary endocrine tumor during pregnancy. After delivery, she underwent radiation and chemotherapy for pulmonary and skeletal metastases. Her disease was clinically stable for 7 yr until she developed bitemporal hemianopia. She had symptoms and signs of acromegaly.
Methods: Imaging, biochemical, and histological studies were performed.
Results: Magnetic resonance imaging (MRI) of the brain confirmed the presence of a 2.6-cm lesion within the sella turcica extending above the sella and compressing the optic chiasm. Endocrine studies showed elevated serum levels of GH, prolactin, alpha-subunit of glycoprotein hormones, IGF-I, chromogranin A, and GHRH. The patient underwent uneventful transsphenoidal resection of the sellar tumor. Postoperatively, she noted an improvement in symptoms of acromegaly. Histological examination confirmed metastatic endocrine carcinoma to the pituitary, and immunohistochemistry localized GHRH to the tumor cells. The adjacent pituitary exhibited somatotroph hyperplasia with abundant reactivity for GH and alpha-subunit. In addition, there was focal neoplastic transformation to a sparsely granulated somatotroph phenotype with fibrous bodies.
Conclusion: This is the first report of a GHRH-producing endocrine tumor metastasizing to the pituitary and causing local hyperstimulation with somatotroph hyperplasia and adenomatous transformation.
Similar articles
- A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
Sanno N, Teramoto A, Osamura RY, Genka S, Katakami H, Jin L, Lloyd RV, Kovacs K. Sanno N, et al. J Clin Endocrinol Metab. 1997 Aug;82(8):2731-7. doi: 10.1210/jcem.82.8.4175. J Clin Endocrinol Metab. 1997. PMID: 9253362 - Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M, Doga M, Bonadonna S, Mazziotti G, Vescovi PP, Giustina A. Gola M, et al. Pituitary. 2006;9(3):221-9. doi: 10.1007/s11102-006-0267-0. Pituitary. 2006. PMID: 17036195 Review. - Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K. Thorner MO, et al. J Clin Invest. 1982 Nov;70(5):965-77. doi: 10.1172/jci110708. J Clin Invest. 1982. PMID: 6290540 Free PMC article. - Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.
Ezzat S, Asa SL, Stefaneanu L, Whittom R, Smyth HS, Horvath E, Kovacs K, Frohman LA. Ezzat S, et al. J Clin Endocrinol Metab. 1994 Mar;78(3):555-60. doi: 10.1210/jcem.78.3.8126126. J Clin Endocrinol Metab. 1994. PMID: 8126126 - Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.
Sano T, Asa SL, Kovacs K. Sano T, et al. Endocr Rev. 1988 Aug;9(3):357-73. doi: 10.1210/edrv-9-3-357. Endocr Rev. 1988. PMID: 3145190 Review.
Cited by
- The Clinicopathological Spectrum of Acromegaly.
Akirov A, Asa SL, Amer L, Shimon I, Ezzat S. Akirov A, et al. J Clin Med. 2019 Nov 13;8(11):1962. doi: 10.3390/jcm8111962. J Clin Med. 2019. PMID: 31766255 Free PMC article. Review. - "Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review".
Mansur G, Alsavaf MB, Pasquini L, Abouammo MD, Biswas C, Kumar P, Raval RR, Kobalka P, Carrau RL, Prevedello DM. Mansur G, et al. Pituitary. 2024 Oct;27(5):455-467. doi: 10.1007/s11102-024-01441-9. Epub 2024 Aug 14. Pituitary. 2024. PMID: 39141205 Free PMC article. - Pituitary Metastatic Composite Tumors: A Case Report with Next-Generation Sequencing and Review of the Literature.
Helton M, Abu-Rmaileh M, Thomas K, Gokden M, Kanaan A, Rodriguez A. Helton M, et al. Case Rep Oncol Med. 2020 Jul 21;2020:5073236. doi: 10.1155/2020/5073236. eCollection 2020. Case Rep Oncol Med. 2020. PMID: 32774962 Free PMC article. - Current diagnosis of acromegaly.
Cordero RA, Barkan AL. Cordero RA, et al. Rev Endocr Metab Disord. 2008 Mar;9(1):13-9. doi: 10.1007/s11154-007-9060-2. Rev Endocr Metab Disord. 2008. PMID: 18236162 Review. - Symptomatic Pituitary Metastasis as Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature.
Gandhi GY, Fung R, Natter PE, Makary R, Balaji KC. Gandhi GY, et al. Case Rep Endocrinol. 2020 Aug 18;2020:8883864. doi: 10.1155/2020/8883864. eCollection 2020. Case Rep Endocrinol. 2020. PMID: 32908722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials